Catalent
CTLT
#1577
Rank
โ‚น916.92 B
Marketcap
โ‚น5,053
Share price
-0.15%
Change (1 day)
28.57%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Net assets

Net assets on the balance sheet as of June 2024 : โ‚น302.35 B

According to Catalent's latest financial reports the company has โ‚น302.35 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Catalent - Net assets on balance sheet (from 2013 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$โ‚น378.38 B0.35%
2022-06-30$โ‚น377.04 B18.72%
2021-06-30$โ‚น317.57 B19.91%
2020-06-30$โ‚น264.83 B67.86%
2019-06-30$โ‚น157.77 B112.12%
2018-06-30$โ‚น74.37 B59.09%
2017-06-30$โ‚น46.75 B9.02%
2016-06-30$โ‚น42.88 B6.24%
2015-06-30$โ‚น40.36 B-280.81%
2014-06-30$-โ‚น22.33 B-8.6%
2013-06-30$-โ‚น24.43 B25.47%
2012-06-30$-โ‚น19.47 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚น80.32 B-73.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น13.76 B-104.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น315.65 B 4.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น6.02 B-98.01%๐Ÿ‡บ๐Ÿ‡ธ USA